Surgery for Locally Unresectable Pancreatic Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Ospedaliera di Padova
About this trial
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
Eligibility criteria
Qualifiers
Patients older than 18 years
Patients able to give informed consent
Histologically confirmed pancreatic adenocarcinoma
LAPC stage according to NCCN10 at diagnosis (Figure 1)
Disqualifiers
Informed consent withdrawal
Presence of tumor characteristics precluding surgery
Presence of patient significant comorbidities precluding surgery
Unavailable pre-induction therapy abdominal imaging
Trial design
Treatments tested in this trial
- Questionnaire
Treatment groups
No treatment groups listed
Sponsors and collaborators
Azienda Ospedaliera di Padova
Lead sponsor
University of Padova
Collaborator
Source ClinicalTrials.gov